Skip to main content

Site notifications

(Approval lapsed) Carbimazole 5mg tablets (Morningside Healthcare)

Section 19A approved medicine
(Approval lapsed) Carbimazole 5mg tablets (Morningside Healthcare)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1301 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
Carbimazole Neo-Mercazole 5mg tablets bottle of 100 - ARTG 194296
Indication(s)

Therapy of hyperthyroidism. Definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. Preparation for thyroidectomy. Before and after radioactive iodine treatment.

Published

Help us improve the Therapeutic Goods Administration site